March 12, 2020 / 10:01 PM / 18 days ago

BRIEF-Geron Reports Q4 Loss Per Share Of $0.15

March 12 (Reuters) - Geron Corp:

* ORATION REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND 2020 MILESTONES

* Q4 LOSS PER SHARE $0.15

* Q4 EARNINGS PER SHARE ESTIMATE $-0.20 — REFINITIV IBES DATA

* Q4 REVENUE ESTIMATE $73,200 — REFINITIV IBES DATA

* SAYS TOPLINE RESULTS FROM PHASE 3 IMERGE CLINICAL TRIAL EXPECTED BY MID-YEAR 2022

* EXPECTS $159.2 MILLION IN CASH AND MARKETABLE SECURITIES AT YEAR-END 2019 WILL BE SUFFICIENT IN 2020 TO CONTINUE TO FUND IMERGE AND COMMENCE PROOF OF CONCEPT STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below